Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
作者信息
Berton A M, Prencipe N, Giordano R, Ghigo E, Grottoli S
机构信息
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy.
Department of Biological and Clinical Sciences, University of Turin, Turin, Italy.
出版信息
J Endocrinol Invest. 2021 Apr;44(4):873-875. doi: 10.1007/s40618-020-01325-2. Epub 2020 Jun 8.
Abstract
摘要
相似文献
1
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.2019冠状病毒病患者使用全身性类固醇：利弊，内分泌学视角
J Endocrinol Invest. 2021 Apr;44(4):873-875. doi: 10.1007/s40618-020-01325-2. Epub 2020 Jun 8.
2
What we have to know about corticosteroids use during Sars-Cov-2 infection.关于 SARS-CoV-2 感染期间使用皮质类固醇的问题，我们必须了解什么。
J Endocrinol Invest. 2021 Apr;44(4):693-701. doi: 10.1007/s40618-020-01384-5. Epub 2020 Aug 28.
3
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.危重症成年患者皮质类固醇功能不全的诊断与管理建议：美国危重病医学会国际特别工作组的共识声明
Crit Care Med. 2008 Jun;36(6):1937-49. doi: 10.1097/CCM.0b013e31817603ba.
4
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.精准皮质类固醇治疗对重症2019新型冠状病毒肺炎的潜在益处。
Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.
5
COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.COVID-19 和非 COVID-19 导致的急性呼吸窘迫综合征患者对低剂量类固醇的反应明显不同——一项回顾性观察研究。
J Crit Care. 2021 Apr;62:46-48. doi: 10.1016/j.jcrc.2020.11.012. Epub 2020 Nov 21.
6
A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.《一例使用甲泼尼龙治疗 SARS-CoV-2 德尔塔变异株所致儿童 Lennox-Gastaut 综合征并严重急性呼吸窘迫综合征的病例报告》。
J Korean Med Sci. 2022 Mar 14;37(10):e82. doi: 10.3346/jkms.2022.37.e82.
7
Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.早期短程皮质类固醇与呋塞米联合治疗非危重症COVID-19患者：一项观察性队列研究。
J Infect. 2021 Jan;82(1):e22-e24. doi: 10.1016/j.jinf.2020.08.045. Epub 2020 Sep 1.
8
COVID-19 and corticosteroids: a narrative review.COVID-19 和皮质类固醇：叙述性综述。
Inflammopharmacology. 2022 Aug;30(4):1189-1205. doi: 10.1007/s10787-022-00987-z. Epub 2022 May 13.
9
Prescribing COVID-19 treatments: what we should never forget.开具新冠治疗药物：我们绝不能忘记的事。
J Infect. 2020 Aug;81(2):e85. doi: 10.1016/j.jinf.2020.05.018. Epub 2020 May 13.
10
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.阿那白滞素联合甲泼尼龙治疗重症 COVID-19 肺炎和炎症过度激活患者：一项观察性队列研究。
J Allergy Clin Immunol. 2021 Feb;147(2):561-566.e4. doi: 10.1016/j.jaci.2020.11.006. Epub 2020 Nov 19.
引用本文的文献
1
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission.copeptin、MR-proADM和MR-proANP单独及与传统严重程度评分联合预测不良结局的有效性：对需要重症监护病房收治的COVID-19患者的二次分析
J Clin Med. 2024 Mar 30;13(7):2019. doi: 10.3390/jcm13072019.
2
The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review.长新冠综合征发病机制中垂体影响的研究进展：综述。
Adv Respir Med. 2024 Feb 14;92(1):96-109. doi: 10.3390/arm92010013.
3
COVID-19 Therapeutic Potential of Natural Products.天然产物在 COVID-19 治疗方面的潜力。
Int J Mol Sci. 2023 May 31;24(11):9589. doi: 10.3390/ijms24119589.
4
Challenges in hyperglycemia management in critically ill patients with COVID-19.2019冠状病毒病危重症患者高血糖管理面临的挑战
World J Crit Care Med. 2022 Jul 9;11(4):219-227. doi: 10.5492/wjccm.v11.i4.219.
5
Lack of Correlation Between Soluble Angiotensin-Converting Enzyme 2 and Inflammatory Markers in Hospitalized COVID-19 Patients with Hypertension.住院COVID-19高血压患者中可溶性血管紧张素转换酶2与炎症标志物之间缺乏相关性。
Infect Drug Resist. 2022 Aug 24;15:4799-4807. doi: 10.2147/IDR.S369771. eCollection 2022.
6
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.新型冠状病毒肺炎与下丘脑-垂体-肾上腺轴的关系：从糖皮质激素不足到过度的大谱- CAPISCO 国际专家小组。
Int J Mol Sci. 2022 Jun 30;23(13):7326. doi: 10.3390/ijms23137326.
7
COVID-19 and corticosteroids: a narrative review.COVID-19 和皮质类固醇：叙述性综述。
Inflammopharmacology. 2022 Aug;30(4):1189-1205. doi: 10.1007/s10787-022-00987-z. Epub 2022 May 13.
8
ENT Manifestations in Patients Suffering from COVID-19: Study from a COVID Hospital in North India.新冠病毒病患者的耳鼻喉科表现：来自印度北部一家新冠专科医院的研究
Int Arch Otorhinolaryngol. 2022 Jan 25;26(1):e148-e151. doi: 10.1055/s-0041-1740987. eCollection 2022 Jan.
9
Real-world evidence of the use of glucocorticoids for severe COVID-19.糖皮质激素用于重症新型冠状病毒肺炎的真实世界证据。
Ther Adv Endocrinol Metab. 2022 Jan 19;13:20420188211072704. doi: 10.1177/20420188211072704. eCollection 2022.
10
Covid-19, the thyroid and the pituitary - The real state of play.Covid-19、甲状腺和垂体——真实的情况。
Ann Endocrinol (Paris). 2022 Apr;83(2):103-108. doi: 10.1016/j.ando.2021.12.004. Epub 2022 Jan 20.
本文引用的文献
1
Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period.2019年冠状病毒病疫情期间内分泌门诊的远程医疗与面对面会诊：封锁期间的单中心经验
J Endocrinol Invest. 2021 Aug;44(8):1689-1698. doi: 10.1007/s40618-020-01476-2. Epub 2020 Dec 23.
2
Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS).早泄的管理：来自意大利男科学和性医学学会 (SIAMS) 的临床指南。
J Endocrinol Invest. 2021 May;44(5):1103-1118. doi: 10.1007/s40618-020-01458-4. Epub 2020 Oct 30.
3
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
4
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.地塞米松治疗急性呼吸窘迫综合征：一项多中心、随机对照试验。
Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.
5
Pharmacological interventions for treatment-resistant depression in adults.成人难治性抑郁症的药物干预措施。
Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD010557. doi: 10.1002/14651858.CD010557.pub2.
6
Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.危重症患者危重症相关皮质类固醇功能不全（CIRCI）诊断与管理指南（第一部分）：危重症医学会（SCCM）和欧洲重症监护医学学会（ESICM），2017年
Crit Care Med. 2017 Dec;45(12):2078-2088. doi: 10.1097/CCM.0000000000002737.
7
Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality.原发性肾上腺皮质功能减退与自然杀伤细胞功能受损有关：这是死亡率增加的一个潜在关联。
Eur J Endocrinol. 2017 Apr;176(4):471-480. doi: 10.1530/EJE-16-0969.
8
Adrenal Insufficiency as a Result of Ritonavir and Exogenous Steroid Exposure: Report of 6 Cases and Recommendation for Management.利托那韦与外源性类固醇暴露导致的肾上腺功能不全：6例报告及管理建议
J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):300-5. doi: 10.1177/2325957414567681. Epub 2015 Jan 14.
9
Molecular mimicry of ACTH in SARS - implications for corticosteroid treatment and prophylaxis.严重急性呼吸综合征中促肾上腺皮质激素的分子模拟——对皮质类固醇治疗和预防的意义
Med Hypotheses. 2004;63(5):855-62. doi: 10.1016/j.mehy.2004.04.009.
Zotero 插件